Marked Reduction in the Risk of Dementia in Patients with Breast Cancer: A Nationwide Population-Based Cohort Study
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose An inverse relationship between cancer and neurodegenerative disease, which presents the possibility of a reduced risk of dementia in cancer patients, has been suggested previously. However, a nationwide longitudinal population-based study of specific types of cancer with due consideration of treatment effects has not been conducted. Materials and Methods This nationwide population-based cohort study used data obtained in a 12-year period (January 2007- December 2018) in the Korean National Health Insurance claims database. All female breast cancer patients (age ≥ 50 years) diagnosed between 2009 and 2010 were included after excluding those with physician visits for any cancer during a 2-year period (2007-2008). Patients with senile cataract constituted the control group. The main study outcome was the risk of developing dementia. Results From a total of 90,396 and 85,906 patients with breast cancer and cataract, respectively, patients without behavior codes were excluded. Data for 15,407 breast cancer patients and 7,020 controls were analyzed before matching. After matching for comorbidities and age, either group comprised 2,252 patients. The median follow-up time was 104.1±24.0 months after matching. After matching, breast cancer was a predictor of a lower risk of for dementia (hazard ratio, 0.091; 95% confidence interval, 0.075 to 0.111; p < 0.001). In breast cancer patients, receiving chemotherapy and endocrine therapy did not significantly affect the incidence of dementia. Conclusion Breast cancer was associated with a remarkably decreased risk of dementia. The findings strongly suggest an inverse relationship between cancer and neurodegeneration, regardless of the adverse effects of cancer treatment on cognitive function.
Abstract
Purpose An inverse relationship between cancer and neurodegenerative disease, which presents the possibility of a reduced risk of dementia in cancer patients, has been suggested previously. However, a nationwide longitudinal population-based study of specific types of cancer with due consideration of treatment effects has not been conducted. Materials and Methods This nationwide population-based cohort study used data obtained in a 12-year period (January 2007- December 2018) in the Korean National Health Insurance claims database. All female breast cancer patients (age ≥ 50 years) diagnosed between 2009 and 2010 were included after excluding those with physician visits for any cancer during a 2-year period (2007-2008). Patients with senile cataract constituted the control group. The main study outcome was the risk of developing dementia. Results From a total of 90,396 and 85,906 patients with breast cancer and cataract, respectively, patients without behavior codes were excluded. Data for 15,407 breast cancer patients and 7,020 controls were analyzed before matching. After matching for comorbidities and age, either group comprised 2,252 patients. The median follow-up time was 104.1±24.0 months after matching. After matching, breast cancer was a predictor of a lower risk of for dementia (hazard ratio, 0.091; 95% confidence interval, 0.075 to 0.111; p < 0.001). In breast cancer patients, receiving chemotherapy and endocrine therapy did not significantly affect the incidence of dementia. Conclusion Breast cancer was associated with a remarkably decreased risk of dementia. The findings strongly suggest an inverse relationship between cancer and neurodegeneration, regardless of the adverse effects of cancer treatment on cognitive function.
참고문헌 (27)
- Jemal A, "Cancer statistics, 2007", CA Cancer J Clin, 57, pp.43~66 (2007)
- Catrysse L, "A20 in inflammation and autoimmunity", Trends Immunol, 35, pp.22~31 (2014)
- Aarsland D, "Prevalence and characteristics of dementia in Parkinson disease : an 8-year prospective study", Arch Neurol, 60, pp.387~392 (2003)
- Brunnstrom H, "Prevalence of dementia subtypes : a 30-year retrospective survey of neuropathological reports", Arch Gerontol Geriatr, 49, pp.146~149 (2009)
- Wolters FJ, "Twenty-seven-year time trends in dementia incidence in Europe and the United States : the Alzheimer Cohorts Consortium", Neurology, 95, pp.e519~31 (2020)
- Lu H, "Comparative analysis of cognitive impairment prevalence and its etiological subtypes in a rural area of northern China between 2010 and 2015", Sci Rep, 9, pp.851~ (2019)
- Catala-Lopez F, "Inverse and direct cancer comorbidity in people with central nervous system disorders : a meta-analysis of cancer incidence in 577, 013 participants of 50 observational studies", Psychother Psychosom, 83, pp.89~105 (2014)
- Yarchoan M, "Association of cancer history with Alzheimer’s disease dementia and neuropathology", J Alzheimers Dis, 56, pp.699~706 (2017)
- Hanahan D, "Hallmarks of cancer : the next generation", Cell, 144, pp.646~674 (2011)
- Shafi O, "Inverse relationship between Alzheimer’s disease and cancer, and other factors contributing to Alzheimer’s disease : a systematic review", BMC Neurol, 16, pp.236~ (2016)
- Nudelman KNH, "Biological hallmarks of cancer in Alzheimer’s disease", Mol Neurobiol, 56, pp.7173~7187 (2019)
- Nixon DW, "The inverse relationship between cancer and Alzheimer’s disease : a possible mechanism", Curr Alzheimer Res, 14, pp.883~893 (2017)
- Lin HL, "Inverse association between cancer and dementia : a population-based registry study in Taiwan", Alzheimer Dis Assoc Disord, 30, pp.118~122 (2016)
- Driver JA, "Inverse association between cancer and Alzheimer’s disease : results from the Framingham Heart Study", BMJ, 344, pp.e1442~ (2012)
- Musicco M, "Inverse occurrence of cancer and Alzheimer disease : a population-based incidence study", Neurology, 81, pp.322~328 (2013)
- Wang XM, "Chemobrain : a critical review and causal hypothesis of link between cytokines and epigenetic reprogramming associated with chemotherapy", Cytokine, 72, pp.86~96 (2015)
- von Elm E, "The Strengthening the Reporting of Observational Studies in Epidemiology(STROBE)statement : guidelines for reporting observational studies", PLoS Med, 4, pp.e296~ (2007)
- Kang Y, "A validity study on the Korean Mini-Mental State Examination(K-MMSE)in dementia patients", J Korean Neurol Assoc, 15, pp.300~308 (1997)
- Choi SH, "Estimating the validity of the Korean version of expanded clinical dementia rating(CDR)scale", J Korean Neurol Assoc, 19, pp.585~591 (2001)
- 최성혜, "한국판 Global Deterioration Scale의 타당도", 대한신경과학회지, 20(6), pp.612~617 (2002), 대한신경과학회
- Austin PC, "Statistical criteria for selecting the optimal number of untreated subjects matched to each treated subject when using many-to-one matching on the propensity score", Am J Epidemiol, 172, pp.1092~1097 (2010)
- Parsons LS, "Performing a 1: N case-control match on propensity score", SAS Institute, ~ (2004)
- Stagg BC, "Association of cognitive impairment and dementia with receipt of cataract surgery among community-dwelling medicare beneficiaries", JAMA Ophthalmol, 137, pp.114~117 (2019)
- Argyriou AA, "Either called"chemobrain"or"chemofog, "the long-term chemotherapy-induced cognitive decline in cancer survivors is real", J Pain Symptom Manage, 41, pp.126~139 (2011)
- Jefferis JM, "Cataract and cognitive impairment : a review of the literature", Br J Ophthalmol, 95, pp.17~23 (2011)
- Xiao Z, "Association of glaucoma and cataract with incident dementia : a 5-year follow-up in the Shanghai aging study", J Alzheimers Dis, 76, pp.529~537 (2020)
- Yu WK, "Cataract surgery is associated with a reduced risk of dementia : a nationwide population-based cohort study", Eur J Neurol, 22, pp.1370~1377 (2015)